Percutaneous Toxicity of Anticoagulant Warfarin in Rats

References

• Lund M. Anticoagulant rodenticides. Rodent Pest Management, I Prakash. CRC Press, Boca Raton, FL 1988; 341–351
   Google Scholar
• Shearer MJ. Vitamin K and vitamin K-dependent proteins. Br J Haematol 1990; 75: 156–162
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Anticoagulant rodenticides. WHO Environmental Health Criteria, No 175, Geneva 1995; 1–121
   Google Scholar
• Sullivan JB, Levine JR, Bangert JL, Maibach H, Hewitt P. Clinical dermatotoxicology. Clinical Environmental Health and Toxic Exposures, JB Sullivan, GR Krieger. Lippincot, Williams & Wilkins, Philadelphia 2000; 182–206
   Google Scholar
• Spiewak R. Pesticides as a cause of occupational skin disease in farmers. Ann Agric Environ Med 2001; 8: 1–5
   PubMed Web of Science ®Google Scholar
• DiPalma JR. Human toxicity form rat poisons. Am Fam Physician 1981; 24: 186–189
   PubMed Web of Science ®Google Scholar
• Friested B, Sterner N. Warfarin intoxication from percutaneous absorption. Arch Environ Health 1965; 11: 205–208
   PubMedGoogle Scholar
• Martin-Boyer G, Khanh NB, Linh PH. Epidemic of hemorrhagic disease in Vietnamese infants caused by warfarin-containing talc. Lancet 1983; 1: 230–232
   PubMed Web of Science ®Google Scholar
• Abell TL, Merigian KS, Lee JM, Holbert JM, McCall JW. Cutaneous exposure to warfarin-like anticoagulant causing an intracerebral hemorrhage: a case report. Clin Toxicol 1994; 32: 69–73
   Web of Science ®Google Scholar
• Farrar A, Cabral R. Recent epidemics of poisoning by pesticides. Toxicol Lett 1995; 82/83: 55–63
   Web of Science ®Google Scholar
• Spiller HA, Gallenstein GL, Murphy MJ. Dermal absorption of a liquid diphacinone rodenticide causing coagulopathy. Vet Hum Toxicol 2003; 45: 313–314
   PubMedGoogle Scholar
• Kataranovski M, Vlaški M, Kataranovski D, Tošić N, Mandić-Radić S, Todorović V. Immunotoxicity of epicutaneously applied anticoagulant rodenticide warfarin: evaluation by contact hypersensitivity to DNCB in rats. Toxicology 2003; 188: 83–100
   PubMed Web of Science ®Google Scholar
• Zhang L, Tinkle SS. Chemical activation of innate and specific immunity in contact dermatitis. J Invest Dermatol 2000; 115: 168–176
   PubMed Web of Science ®Google Scholar
• Kataranovski M, Drašković-Pavlović B, Jovčić G, Milojević G, Todorović V, Čolić M, Popović P. Peripheral blood granulocyte activity following contact sensitization of rats with dinitrochlorobenzene. Toxicology 2001; 162: 121–136
   PubMed Web of Science ®Google Scholar
• Oez S, Welte K, Platzer E. A quantitative colorimetric method to evaluate the functional state of human polymorphonuclear leukocytes. Blut 1990; 60(2)97–102
   PubMedGoogle Scholar
• Monboisse JC, Garnotel R, Randoux A, Dufer J, Borel JP. Adhesion of human neutrophils to and activation by type-I collagen involving a beta2 integrin. J Leukoc Biol 1991; 50(4)373–380
   PubMed Web of Science ®Google Scholar
• Owens JM, Guiney P, Howard PH, Aronson DB, Gray A. Indoor household pesticides: hazardous waste concern or not?. Rev Environ Contam Toxicol 2000; 164: 27–68
   PubMed Web of Science ®Google Scholar
• Dreyfus M, Dubouch P, Pierson K, Neveu Y, Martin E, Tchernia G. Warfarin-contaminated talc. Lancet 1983; 1: 1110
   PubMed Web of Science ®Google Scholar
• Schwartz J, Weiss ST. Host and environmental factors influencing the peripheral blood leukocyte counts. Am J Epidemiol 1991; 134: 1402–1409
   PubMed Web of Science ®Google Scholar
• Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Meth 1986; 89: 271–277
   PubMed Web of Science ®Google Scholar
• Berridge MV, Tan AS, McCoy KD, Wang R. The biochemical and cellular basis of cell proliferation assay that use tetrazolium salts. Biochemica 1996; 4: 15–20
   Google Scholar
• Kakinuma K, Fukuhara Y, Kaneda M. The respiratory burst oxidase of neutrophils. J Biol Chem 1987; 262(25)12324–12361
   Google Scholar
• Murakami K, Okajima K, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996; 87: 642–647
   PubMed Web of Science ®Google Scholar
• Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ishemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95: 3781–3787
   PubMed Web of Science ®Google Scholar
• Shibata M, Ram Kumar S, Amar A, Fernandez JA, Hofman F, Griffin JH, Zlokovic BV. Antiinflammatory, antithrombotic and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 2001; 103: 1799–1805
   PubMed Web of Science ®Google Scholar
• Chan JCYC, Ganopolsky JG, Cornelissen I, Suckow MA, Sandoval Cooper MJ, Brown EC, Noria F, Gailani D, Rosen ED, Proplis VA, Castellino FJ. The characterization of mice with a targeted combined deficiency of protein C and factor XI. Am J Pathol 2001; 158: 469–479
   PubMed Web of Science ®Google Scholar
• Taylor F, Chang G, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT. C4b-binding protein exacerbates the host response to Escherichia colli. Blood 1991; 78: 357–363
   PubMed Web of Science ®Google Scholar
• Taylor FB, Stearn-Kurosawa DJ, Kurosawa S, Ferrell G, Chang CK, Laszik S, Kosanke S, Peer G, Esmon CT. The endothelial cell protein C receptor aids in host defense against Escherichia colli sepsis. Hemost Thromb Vasc Biol 2000; 95: 1680–1686
   Google Scholar
• Tokunaga F, Wakabayashi S, Koide T. Warfarin causes the degradation of protein C precursor in the endoplasmic reticulum. Biochemistry 1995; 34: 1163–1170
   PubMed Web of Science ®Google Scholar
• Furie B. Oral anticoagulant therapy. Hematology. Basic Principle and Practice, R Hoffman, EJ Benz, SJ Shatill, B Furie, JH Cohen, LE Silberstein, P McGlave. A Harcourt Health Science Company, Philadelphia: Churchill Livingstone 2000; 2040–2046
   Google Scholar
• Kimber I, Cumberbatch M, Humhreys M, Hopkins SJ. Contact hypersensitivity induces plasma interleukin-6. Int Arch Allergy Appl Immunol 1990; 92(1)97–99
   PubMedGoogle Scholar
• Kataranovski M, Vlaški M, Kataranovski D. Peripheral blood granulocyte activity following epicutaneous application of sodium dodecyl sulphate (SDS) in rats. Cutan Ocul Toxicol 2004; 23(4)263–275
   Web of Science ®Google Scholar
• Kataranovski M, Prokić V, Kataranovski D, Zolotarevski L, Majstorović I. Dermatotoxicity of epicutaneously applied anticoagulant warfarin. Toxicology 2005; 212: 206–218
   PubMed Web of Science ®Google Scholar
• Kataranovski M, Kataranovski D, Zolotarevski L, Jović M. Epicutaneous exposure to anticoagulant rodenticide warfarin modulates local skin activity in rats. Cutan Ocul Toxicol 2007; 26(1)1–13
   PubMed Web of Science ®Google Scholar